Antibody drug conjugates
and Carbohydrate Synthes
is
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Guidelines and tips
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community
Ask the community for help and clear up your study doubts
University Rankings
Discover the best universities in your country according to Docsity users
Free resources
Our save-the-student-ebooks!
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
BOC Sciences' ADCs and Carbohydrate Synthesis for Cancer Treatment and Research, Exercises of Chemistry
Information about antibody drug conjugates (adcs) and boc sciences' services in carbohydrate synthesis. Adcs are targeted therapies for cancer treatment, combining the high specificity and antitumor activity of monoclonal antibodies with the cell-killing activity of small molecule drugs. Boc sciences offers design, synthesis, and characterization of carbohydrate-based molecules, as well as screening libraries and chemical synthesis services. Their expertise in enzyme synthesis also contributes to the production of new classes of reagents and products.
What you will learn
- What are the benefits of using ADCs in cancer treatment?
- What services does BOC Sciences offer in the field of carbohydrate synthesis?
- What are Antibody Drug Conjugates (ADCs) and why are they important?
Typology: Exercises
2016/2017
1 / 7
This page cannot be seen from the preview
Don't miss anything!
Related documents
Partial preview of the text
Download BOC Sciences' ADCs and Carbohydrate Synthesis for Cancer Treatment and Research and more Exercises Chemistry in PDF only on Docsity!
Antibody drug conjugates
and Carbohydrate Synthes
is
Antibody drug conjugates
- (^) Antibody-drug conjugates (ADCs) are a very impor tant class of highly potent drugs designed as a tar geted therapy for the treatment of people who ha s cancer. It represents an innovative therapeutic a pplication that includes the unique, high specificit y and antitumor activity of monoclonal antibodies which are tumor-specific but not very cytotoxic, wi th the cell killing activity of small molecule drugs t hat are too toxic to be used on their own. Scientist s could optimize the features of both components by linking monoclonal antibodies with cytotoxic ag ents.
Presented above are the product and s ervice BOC Sciences launched to bett er meet the related needs. Then Scre ening Libraries, and chemical synthe sis, and enzyme synthesis are enha nced.
Screening Libraries
- (^) Composed of an assortment of twent y-one libraries including FDA-approve d drug library, natural product library , and anti-cancer compound library, a mong others, the bioactive screening libraries at BOC Sciences are ready-t o-use chemical libraries for drug disc overy, lab drug screening, drug targe t identification, and other pharmaceu tical-related applications.
Enzyme synthesis
- (^) The maturing petroleum-based chem ical industry, the pressures of environ mental constraints and the explosive development of biotechnology have i ncreased the interest in catalysis in e nzymology. Enzymes are now an attr active proposition as catalysts for ne w classes of reagents and products, e specially sugars, chiral synthons, met abolites and food components.